A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)
Clinical trial NCT02532855 · COMPLETED
Trial details
- NCT number
- NCT02532855
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-20
- Primary completion
- 2017-10-10
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.